Literature DB >> 26709662

BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.

Allal Ouhtit1, Ishita Gupta2, Zoya Shaikh3.   

Abstract

BRIP1 encodes a protein belonging to the RecQ DEAH helicase family. It interacts with BRCA1, and is involved in the repair of DNA damage and tumor suppression. Aberrations in BRIP1 have been mainly associated with the development of breast cancer (BC), ovarian cancer, and type J Fanconi anemia. Based on recent work, we hypothesize that BRIP1 might be the gene involved in the onset of BC in families that do not show BRACA1/2 mutations. This review will focus on the findings supporting this hypothesis, the mechanisms linking BRIP1 to the onset of BC, and the potential clinical relevance of its various inhibitors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26709662     DOI: 10.2741/E767

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  9 in total

1.  Whole exome sequencing of breast cancer (TNBC) cases from India: association of MSH6 and BRIP1 variants with TNBC risk and oxidative DNA damage.

Authors:  M Aravind Kumar; Shaik Mohammad Naushad; Narasimhulu Narasimgu; S Nagaraju Naik; Srilatha Kadali; Uday Shanker; M Lakshmi Narasu
Journal:  Mol Biol Rep       Date:  2018-08-22       Impact factor: 2.316

2.  Genomic architecture of Shh-dependent cochlear morphogenesis.

Authors:  Victor Muthu; Alex M Rohacek; Yao Yao; Staci M Rakowiecki; Alexander S Brown; Ying-Tao Zhao; James Meyers; Kyoung-Jae Won; Shweta Ramdas; Christopher D Brown; Kevin A Peterson; Douglas J Epstein
Journal:  Development       Date:  2019-09-19       Impact factor: 6.868

Review 3.  The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations.

Authors:  Sarah Macklin; Jennifer Gass; Ghada Mitri; Paldeep S Atwal; Stephanie Hines
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

Review 4.  Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.

Authors:  Gabriela A Martínez-Nava; Julián A Fernández-Niño; Vicente Madrid-Marina; Kirvis Torres-Poveda
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

Review 5.  Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets.

Authors:  Can-Bin Fang; Hua-Tao Wu; Man-Li Zhang; Jing Liu; Guo-Jun Zhang
Journal:  Front Cell Dev Biol       Date:  2020-04-02

Review 6.  Homologous Recombination Deficiencies and Hereditary Tumors.

Authors:  Hideki Yamamoto; Akira Hirasawa
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 7.  Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway.

Authors:  Akiko Abe; Issei Imoto; Arisa Ueki; Hidetaka Nomura; Hiroyuki Kanao
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

8.  The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast Cancer.

Authors:  Sanrong Li; Jing Ma; Caiying Hu; Xing Zhang; Deyong Xiao; Lili Hao; Wenjun Xia; Jichun Yang; Ling Hu; Xiaowei Liu; Minghui Dong; Duan Ma; Rensheng Liu
Journal:  J Breast Cancer       Date:  2018-08-28       Impact factor: 3.588

9.  HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer.

Authors:  Vic Hart; Marco Silipo; Swapna Satam; Hannah Gautrey; John Kirby; Alison Tyson-Capper
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-16       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.